- Filed
- Apr 6, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Apr 4, 2022 | 559.28M sh |
| Shares Diluted | FY 2021 · Dec 31, 2021 | 559.28M sh |
| Shares Diluted | FY 2021 · Dec 31, 2020 | 593.05M sh |
| Capex | FY 2021 · Dec 31, 2021 | $0 |
| Capex | FY 2021 · Dec 31, 2020 | $4K |
| Operating Cash Flow | FY 2021 · Dec 31, 2020 | −$388K |
| Cash And Equivalents | FY 2021 · Dec 31, 2020 | $353K |
| Cash And Equivalents | FY 2021 · Dec 31, 2019 | $261K |
| Current Liabilities | FY 2021 · Dec 31, 2020 | $1.01M |
| Total Liabilities | FY 2021 · Dec 31, 2020 | $1.12M |
| Current Assets | FY 2021 · Dec 31, 2020 | $665K |
| Total Assets | FY 2021 · Dec 31, 2020 | $6.85M |
| Eps Diluted | FY 2021 · Dec 31, 2020 | $0.01 |
| Eps Basic | FY 2021 · Dec 31, 2020 | $0.01 |
| Sga Expense | FY 2021 · Dec 31, 2020 | $714K |
| Rd Expense | FY 2021 · Dec 31, 2020 | $11K |
| Net Income | FY 2021 · Dec 31, 2020 | $4.31M |
| Operating Income | FY 2021 · Dec 31, 2020 | −$675K |
| Revenue | FY 2021 · Dec 31, 2020 | $50K |
| Stockholders Equity restated | FY 2021 · Dec 31, 2019 | −$1.01M |